Oral appliances, one of the treatment options for obstructive sleep apnoea syndrome (OSAS), is used to treat mild and moderate OSAS. The aim of this study was to summarise the pathogenesis, epidemiology, diagnosis, and main treatment options of OSAS. A MedLine literature search was performed to identify articles associated with a dental approach to OSAS. It causes snoring, airway obstruction, and sleep disruption. Treating OSAS is important, and it can be managed successfully with an oral appliance. Oral appliances may be an alternative to other OSAS treatments because they are easily tolerated. Oral appliances offer a safe, effective, and noninvasive treatment option for OSAS.
INTRODUCTION
Obstructive sleep apnoea syndrome (OSAS) is a respiratory sleep disorder that progresses into snoring, apnoea, and daytime sleepiness and can occasionally affect all organs and systems.
OSAS is a condition characterised by frequent obstruction of the upper respiratory tract; thus, blood oxygen saturation decreases during sleep. Apnoea is usually terminated by noisy snoring or waking up. All individuals who snore are potential candidates for OSAS.
Classification
In 1997, the American Sleep Disorders Association (ASDA) defined OSAS as 'a disorder that is characterized by recurrent episodes of upper respiratory tract obstruction and decreased blood oxygen saturation during sleep'. OSAS classifications are based on apnoea-hypopnoea index (AHI) value (Table 1) . It is critical to identify whether OSAS is present in patients with a complaint of snoring.
Primary snoring is a social disorder with optional treatments. However, OSAS is a disorder that can cause serious morbidity and even mortality, and treatment is warranted.
Polysomnography (PSG) is the only definitive test for identifying OSAS.(1-3)

Epidemiology
The prevalence rate of OSAS is estimated to be 1.2-2.5% in the adult female population and 1-5% in the adult male population. (4, 5) In 1995, Stradling(6) conducted a study to assess 
Clinical Diagnosis
Conceivably, clinical diagnosis is the most important method among diagnostic modalities other than PSG (Table 3) . 
Treatment of OSAS
Early diagnosis and, more importantly, appropriate management are critically important for patients with OSAS, a disorder that has serious consequences, including death during sleep.
As such, AHI values are important in patients with OSAS. Although treatment is planned according to AHI value, it is necessary to plan treatment by assessing each patient individually, considering the pros and cons of treatment and obtaining the patient's consent.
The treatment modalities include positive airway pressure therapy, surgical treatment, and intraoral appliances.
Positive Airway Pressure Therapy
Continuous positive airway pressure (CPAP)
A CPAP device is a device that provides patency of the upper respiratory tract mechanically by providing room air to the patient at a certain pressure level. The system includes a highspeed generator, a low-resistance tube, a pressure regulator, and a nasal mask. The device provides constant upper respiratory tract pressure by decreasing flow at the same level of pressure that increases during expiration and increasing flow at the same amount of pressure that decreases during inspiration. (18) PSG studies of OSAS patients using CPAP therapy have shown that apnoea-hypopnea episodes disappear, increased respiratory efforts and heart rate return to normal, and oxygen saturation levels increase. CPAP therapy can improve all OSAS complications when it is successful.
CPAP-related side effects are rare. The most frequent adverse events include intolerance to breathing pressurised air, nasal congestion, and cutaneous irritations caused by the mask
Bilevel positive airway pressure (BPAP)
BPAP was developed as an alternative to CPAP. During sleep, airway resistance and the tendency toward airway obstruction are higher during expiration compared to inspiration.
Thus, the aim of BPAP is to achieve better tolerance by applying lower pressure during expiration than during inspiration, rather than applying constant pressure. 
Mandibular advancement devices
The aim of MAD devices is to widen and stabilise the distance between the root of the tongue and the oropharynx by advancing the mandible forward. (28, 29) These devices have varying effects on the airway. They change the geometry of the pharyngeal region, resulting in a larger retropalatal area due to the increased size in the lateral aspect. The amount of increase in the lateral diameter of the airway is greater than the increase in sagittal diameter, and the increase in size of both the lateral and sagittal directions at the retroglossal level result in an increased pharyngeal area. (12) MAD is appropriate for use in mild or moderate OSAS cases with micrognathia, obese patients, and patients incapable of nasal breathing.
The patient-related factors that have a role in the successful use of these devices include normal or decreased facial length, normal position of mandible according to cranial base, normal intermaxillary distance, small ratio of soft palate or tongue to functional area, and at least eight teeth in the mandible and maxilla. A thicker soft palate and excessive tongue area can cause failure of mandibular advancement devices.
Tongue-retaining devices
TRDs were first used by Cartwright and Samelson in 1982.(30) In this method, the tongue is retracted anterior to the incisors and stabilised during sleep. Activity of the genioglossus muscle is increased in OSAS patients using this device,(31) leading to increased volume and decreased resistance of the upper airway. These devices are preferred in patients with large tongues, patients with chronic temporomandibular joint pain that prevents anterior shifting of the mandible, and patients with fewer than six teeth in each arc. It has been reported that while AHI value typically decreases by 50% in 50-75% of patients, AHI decreased below 10% in 25-73% of patients using TRD therapy. (29, 32, 33) Palate-stabilising devices Palate-stabilising devices reduce the vibration that causes snoring by stabilising the soft palate.(34) These devices are rarely used because it is difficult to tolerate them. 
Indications for Intraoral Device Use
